Literature DB >> 22648746

Steroid hormone receptors, matrix metalloproteinases, insulin-like growth factor, and dystroglycans interactions in prostatic diseases in the elderly men.

A C Hetzl1, W J Fávaro, A Billis, U Ferreira, V H A Cagnon.   

Abstract

OBJECTIVES: The aim of this study was to evaluate the reactivity of steroid hormone receptors (SHRs), dystroglycans (DGs), matrix metalloproteinases (MMPs), insulin-like growth factor receptor (IGFR-1), and laminin (Lam) in both prostatic stromal and epithelial compartments showing different diseases in elderly men.
METHODS: Sixty prostatic samples were obtained from 60- to 90-year-old patients (mean 63 years) with and without prostatic lesions from Hospital of the School of Medicine, State University of Campinas (UNICAMP). The Samples were divided into standard (no lesions); high grade prostatic intraepithelial neoplasia (HGPIN); prostatic cancer (PC); and benign prostatic hyperplasia (BPH) groups. The samples were submitted to immunohistochemistry and Western blotting analyses. Research Ethics Committee of the School of Medicine, University of Campinas/UNICAMP (number 0094.0.146.000-08).
RESULTS: The results showed increased IGFR-1 and MMPs protein levels in the PC and HGPIN groups. Decreased αDG and βDG protein levels were verified in the PC and HGPIN groups. Androgen receptor (AR) reactivity was similar among all groups. Estrogen receptor α (Erα) immunoreactivity was more intense in the epithelium in the PC and HGPIN groups. Estrogen receptor β (ERβ) immunoreactivity was weak in the epithelium of the HGPIN and PC groups.
CONCLUSIONS: To conclude, there was an association among IGFR-1, MMPs, and SHRs, indicating IGFR-1 as a target molecule in prostate therapy, considering the IGF proliferative properties. Also, the distinct SHRs reactivities in the lesions in both prostatic compartments indicated different paracrine signals and pointed out the importance of estrogenic pathways in the activation of these disorders.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648746     DOI: 10.1002/jemt.22049

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  6 in total

1.  Antiangiogenic therapy effects on age-associated matrix metalloproteinase-9 (MMP-9) and insulin-like growth factor receptor-1 (IGFR-1) responses: a comparative study of prostate disorders in aged and TRAMP mice.

Authors:  Fabio Montico; Larissa Akemi Kido; Amanda Cia Hetzl; Raísa Mistieri Lorencini; Eduardo Marcelo Cândido; Valéria Helena Alves Cagnon
Journal:  Histochem Cell Biol       Date:  2014-02-22       Impact factor: 4.304

2.  Sex steroid receptor expression and localization in benign prostatic hyperplasia varies with tissue compartment.

Authors:  Tristan M Nicholson; Priyanka D Sehgal; Sally A Drew; Wei Huang; William A Ricke
Journal:  Differentiation       Date:  2013-06-20       Impact factor: 3.880

3.  Differential expression of androgen, estrogen, and progesterone receptors in benign prostatic hyperplasia.

Authors:  Lingmin Song; Wenhao Shen; Heng Zhang; Qiwu Wang; Yongquan Wang; Zhansong Zhou
Journal:  Bosn J Basic Med Sci       Date:  2016-06-13       Impact factor: 3.363

4.  Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats.

Authors:  Mônica Morais-Santos; Aryane E B Nunes; André G Oliveira; Júnia Dayrell Moura-Cordeiro; Germán A B Mahecha; Maria Christina W Avellar; Cleida A Oliveira
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

Review 5.  Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis.

Authors:  Sean Harrison; Rosie Lennon; Jeff Holly; Julian P T Higgins; Mike Gardner; Claire Perks; Tom Gaunt; Vanessa Tan; Cath Borwick; Pauline Emmet; Mona Jeffreys; Kate Northstone; Sabina Rinaldi; Stephen Thomas; Suzanne D Turner; Anna Pease; Vicky Vilenchick; Richard M Martin; Sarah J Lewis
Journal:  Cancer Causes Control       Date:  2017-03-30       Impact factor: 2.506

Review 6.  The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.

Authors:  Marley J Binder; Alister C Ward
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.